Synonyms:JNJ-7706621, 443797-96-4, JNJ7706621, 4-((5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)benzenesulfonamide, UNII-74GK72DON8, 4-[[5-amino-1-(2,6-difluorobenzoyl)-1,2,4-triazol-3-yl]amino]benzenesulfonamide, RWJ-387252, JNJ 7706621, 4-[[5-Amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino]benzenesulfonamide, 74GK72DON8, CHEMBL191003, 4-({5-Amino-1-[(2,6-Difluorophenyl)carbonyl]-1h-1,2,4-Triazol-3-Yl}amino)benzenesulfonamide, 4-(5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-ylamino)benzenesulfonamide, 3ama, 4-{[5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl]amino}benzenesulfonamide, SKE, JNJ-770662, Kinome_3748, Aurora Kinase/Cdk Inhibitor, MLS006011037, BDBM6866, GTPL5932, SCHEMBL1060773, C15H12F2N6O3S, CHEBI:94506, cid_5330790, DTXSID40416207, SYN1048, BCPP000198, HMS3244O15, HMS3244O16, HMS3244P15, HMS3654J07, AOB87730, BCP01836, EX-A1979, ZINC3938688, s1249, AKOS016009412, BCP9000805, CCG-264878, CS-0179, SB19461, Benzenesulfonamide, 4-((5-amino-1-(2,6-difluorobenzoyl)-1H-1,2,4-triazol-3-yl)amino)-, NCGC00263151-01, NCGC00263151-08, 1H-1,2,4-Triazole-3,5-diamine, N3-(4-(aminosulfonyl)phenyl)-1-(2,6-difluorobenzoyl)- 4-((5-amino-1-(2,6-difluorobenzoyl)-1H-(1,2,4)triazol-3-yl)amino)benzenesulfonamide, AC-32855, AS-16208, HY-10329, QC-11795, SMR004702830, A4115, FT-0706504, SW219396-1, X7429, A19402, C75199, JNJ-7706621,JNJ7706621, 797A964, J-513580, BRD-K11636097-001-01-5, Q27074622, 1-Acyl-1H-[1,2,4]triazole-3,5-diamine Analogue 3b, 4-[[5-amino-1-(2,6-difluorobenzoyl)-1h-1,2,4-triazol-3-yl]amino]-benzenesulfonamide, 4-[5-amino-1-(2,6-difluorobenzoyl)-1H-[1,2,4]triazol-3-ylamino]-benzenesulfonamide, 4-({5-amino-1-[(2,6-difluorophenyl)carbonyl]-1H-1,2,4-triazol-3-yl}amino)benzene-1-sulfonamide, JNJ-7706621; 4-(5-Amino-1-(2,6-difluorobenzoyl)-1H-[1,2,4]triazol-3-ylamino)-benzenesulfonamide
Id:5330790
Description:nan
